Logout
If you want to log out click in LogOut
Inflammation signaling pathways play a central role in coordinating immune responses to infection, tissue injury, and cellular stress.
These pathways allow cells to detect danger signals and translate them into coordinated molecular responses involving cytokine production, immune cell activation, and tissue repair. While essential for host defense, inflammatory signaling must be tightly regulated to prevent excessive damage.
Understanding inflammation signaling pathways is critical for identifying biomarkers and analyzing immune activation at the molecular level.
However, inflammation is not driven by a single pathway. It results from the interaction of multiple signaling networks, making its analysis inherently complex. Dysregulation of these pathways is associated with chronic diseases such as cancer, autoimmune disorders, cardiovascular diseases, and neurodegeneration.
In practice, inflammation signaling pathways are commonly analyzed using gene expression profiling and qPCR-based approaches to characterize pathway activation and identify disease-associated biomarkers.
Inflammation signaling pathway biomarker list
View the genes and molecular targets included in our inflammation pathway qPCR arrays.
Inflammation involves a broad and interconnected network of genes regulating immune activation, mediator production, and tissue responses.
These gene sets provide a strong foundation for designing customized qPCR panels for targeted inflammation pathway analysis
These characteristics make inflammation signaling pathways highly relevant across multiple research and disease contexts.
Studying inflammation signaling pathways is essential to understand how immune responses become dysregulated and contribute to disease progression.
They are particularly relevant for:
Inflammation signaling pathways rely on a complex and highly interconnected network of molecular systems, including cytokine signaling, lipid mediators, complement activation, and growth factor pathways.
This section highlights representative genes involved in inflammation signaling pathways. The complete biomarker panel includes a broader set of genes covering additional regulatory mechanisms.
Representative genes
PTGS1, PTGS2, LTC4S, LTB4R, IL1A, IL1B, IL6, IL8, IL10, TNF, CCL2, IFNB1, IFNG, IFNAR1, IFNAR2
These genes are commonly used to assess inflammation pathway activation and immune response dynamics.
Explore the full gene panel used for inflammation signaling pathways analysis.
Inflammatory responses are orchestrated by a network of core signaling pathways:
Toll-like receptor (TLR) signaling pathway
Inflammasome signaling
Together, these pathways form an integrated inflammatory signaling network.
Failure to resolve inflammatory signaling is a hallmark of chronic pathology.
Infectious diseases
Efficient inflammatory signaling is required for pathogen clearance, while excessive activation can cause tissue damage.
Autoimmune and inflammatory disorders
Chronic activation contributes to: Rheumatoid arthritis, Inflammatory bowel disease, Psoriasis, Asthma.
Cancer
Inflammatory signaling promotes: Tumor cell survival, Angiogenesis, Immune evasion, Metastatic progression.
Neurodegenerative and cardiovascular diseases
Inflammation drives: Neuroinflammation and neuronal damage, Atherosclerosis and cardiac dysfunction.
Inflammation pathways represent major therapeutic targets:
Precise molecular profiling is essential to guide targeted interventions.
Analyzing inflammation requires precise tools capable of capturing complex and interconnected signaling networks.
AnyGenes® supports researchers with customized qPCR panels designed for inflammation signaling pathways analysis and biomarker discovery.
Key advantages:
Analyzing inflammation is inherently complex due to extensive cross-talk between pathways and cell types.
A major challenge in inflammation analysis is distinguishing between transient activation and sustained pathological signaling.
Workflow:
Targeted gene panels are essential to focus on relevant biomarkers and reduce variability.
qPCR-based approaches enable robust, sensitive, and reproducible analysis of inflammation signaling pathways.
Customized qPCR panels allow precise investigation of pathway interactions and immune activation states.
Compared to transcriptomic approaches, qPCR provides faster, cost-effective, and reproducible analysis for focused studies.
Scientific data is only as powerful as the analysis behind it.
AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.
What does it allow you to do?
Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
[email protected]
to initiate your project.
They are molecular signaling cascades that regulate immune activation, cytokine production, and tissue responses to injury or infection.
Key pathways include NF-κB, MAPK, JAK-STAT, Toll-like receptor signaling, and inflammasome pathways.
Acute inflammation is rapid and protective, while chronic inflammation is persistent and contributes to disease development.
Persistent inflammatory signaling drives autoimmune disorders, cancer, cardiovascular diseases, and neurodegeneration.
By measuring the expression of pathway regulators and downstream targets using targeted gene expression approaches such as qPCR pathway arrays.
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Inflammation | IF1H1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Inflammation | IF1M1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Inflammation | IF1R1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Inflammation | ******* |
Biomarker list in progress. |
Looking for more answers? Visit our Help & FAQ section to find detailed information about our products, services, and technical support.
1. Miguel Lourenço Varela et al. Acute Inflammation and Metabolism. Inflammation. (2018);41(4):1115-1127.
2. Yu W, et al. Advances in T Cells Based on Inflammation in Metabolic Diseases. Cells. (2022)10;11(22):3554.
3. Luis F García. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol. (2020);11:1441.
4. Michele Catanzaro et al. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther. (2020);5(1):84.
5. Ning Yuan et al. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry. (2019);9(1):233.
6. Estella A Newcombe et al. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease. J Neuroinflammation. 2018;15(1):276.
7. Peter Libby and Sebastian Kobold. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology. Cardiovasc Res. 2019;115(5): 824–829.
8. Zarrin AA, et al. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov. (2021);20(1):39-63..
9. Christina H Liu et al. Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities. Nat Immunol. 2017;18(11):1175-1180.